[Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node]. 1982

M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo

The effects of two immunomodulators, levamisole and lentinan, on cell-mediated immunity and regional lymph nodes of patients with gastric cancer were studied, including reference to some literature. 1) The counts of active T-cells and total T-cells in the peripheral blood showed a tendency of increase after administration of levamisole. 2) PHA lymphocyte blastoformation in the peripheral blood with and without autoserum was enhanced by the administration of levamisole and lentinan. 3) The percentage of active T-cells and PHA lymphocyte blastoformation in the peripheral blood with and without autoserum in proximal regional lymph nodes were increased by the administration of levamisole and lentinan. 4) The percentage of active T-cells and PHA lymphocyte blastoformation in the peripheral blood with and without autoserum in distal regional lymph nodes were increased by the administration of levamisole. 5) Postoperative depression of PHA and PPD skin tests was enhanced by preoperative administration of levamisole, and that of PHA skin test was enhanced by the administration of lentinan.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007912 Lentinan Polysaccharide isolated from the edible mushroom LENTINULA EDODES. The exact composition is unknown.
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
October 1981, Nihon Gan Chiryo Gakkai shi,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
December 1983, Acta medica Okayama,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
April 1985, Fukuoka igaku zasshi = Hukuoka acta medica,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
December 1985, Nihon Gan Chiryo Gakkai shi,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
October 1977, Acta medica Okayama,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
September 1980, Acta medica Okayama,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
November 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
M Takeshita, and T Kobori, and E Sudo, and Y Miyamoto, and M Izuo
June 1982, Nihon Gan Chiryo Gakkai shi,
Copied contents to your clipboard!